Marker Therapeutics (MRKR) PT Lowered to $11 at Oppenheimer
Tweet
Share
E-mailGet Alerts MRKR Hot Sheet
Price: $1.16 +1.75%
Rating Summary:
9 Buy, 1 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 22
Rating Summary:
9 Buy, 1 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 22
Join SI Premium – FREE
Oppenheimer analyst Matthew Biegler lowered the price target on Marker Therapeutics (NASDAQ: MRKR) to $11.00 (from $13.00) while maintaining a Outperform rating.
You May Also Be Interested In
- Citi Downgrades Lend Lease Group (LLC:AU) (LLESY) to Neutral
- Yokogawa Electric Corp (6841:JP) PT Raised to JPY5,700 at Citi
- Citi Downgrades Northern Star Resources (NST:AU) (NESRF) to Neutral
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
